Top 10 Stocks To Own For 2019

HubSpot, Inc. (NYSE:HUBS) has earned a consensus rating of “Buy” from the eighteen brokerages that are covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $113.27.

A number of research analysts have weighed in on HUBS shares. Zacks Investment Research cut shares of HubSpot from a “hold” rating to a “sell” rating in a research report on Monday, February 19th. UBS Group cut shares of HubSpot from a “buy” rating to a “neutral” rating and set a $123.00 price objective on the stock. in a research report on Thursday, March 8th. Evercore ISI cut shares of HubSpot from an “outperform” rating to an “in-line” rating and set a $90.00 price objective on the stock. in a research report on Monday, March 12th. They noted that the move was a valuation call. ValuEngine upgraded shares of HubSpot from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. Finally, Bank of America boosted their price objective on shares of HubSpot from $115.00 to $130.00 and gave the company a “buy” rating in a research report on Wednesday, April 18th.

Top 10 Stocks To Own For 2019: Cresud S.A.C.I.F. y A.(CRESY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News coverage about Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cresud S.A.C.I.F. y A. earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned news stories about the company an impact score of 47.6414670877177 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Shane Hupp]

    Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 294,367 shares, a decline of 44.8% from the April 30th total of 533,376 shares. Based on an average daily volume of 179,726 shares, the days-to-cover ratio is presently 1.6 days.

Top 10 Stocks To Own For 2019: Xenon Pharmaceuticals Inc.(XENE)

Advisors’ Opinion:

  • [By Alexander Bird]

    Here are last week’s top-performing penny stocks:

    Penny Stock Current Share Price Last Week’s Gain
    Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11%
    Nano Dimension (Nasdaq: NNDM) $2.61 75.11%
    Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84%
    CLPS Inc. (Nasdaq: CLPS) $9.72 71.15%
    NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33%
    Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82%
    Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70%
    Polymet Mining Corp. (NYSE: PLM) $1.01 31.13%
    Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%

    Many investors struggle with finding stocks with this sort of breakout potential because they don’t know where to look.

  • [By Chris Lange]

    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares saw a handy gain on Tuesday after the firm announced positive data from a couple of its trials. Specifically, Xenon presented data from its XEN901 Phase 1 clinical trial and from its XEN1101 Phase 1 clinical trial at the Eilat Conference on New Antiepileptic Drugs and Devices in Madrid, Spain.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Ethan Ryder]

    Xenon Pharmaceuticals Inc (NASDAQ:XENE) traded up 2.7% during mid-day trading on Monday . The stock traded as high as $11.00 and last traded at $9.60. 1,488 shares changed hands during trading, a decline of 100% from the average session volume of 400,794 shares. The stock had previously closed at $9.35.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Xenon Pharmaceuticals (XENE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Own For 2019: Intec Pharma Ltd.(NTEC)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Intec Pharma (NTEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Media stories about Intec Pharma (NASDAQ:NTEC) have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intec Pharma earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 45.6707447165993 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Joseph Griffin]

    Intec Pharma (NASDAQ:NTEC) has been assigned a $15.00 target price by Oppenheimer in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the biotechnology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 185.71% from the company’s current price.

  • [By Max Byerly]

    Headlines about Intec Pharma (NASDAQ:NTEC) have trended somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intec Pharma earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 45.4513319646459 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 10 Stocks To Own For 2019: MYR Group Inc.(MYRG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on MYR Group (MYRG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Max Byerly]

    News headlines about MYR Group (NASDAQ:MYRG) have been trending somewhat positive on Thursday, Accern reports. Accern scores the sentiment of press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MYR Group earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned media coverage about the utilities provider an impact score of 46.210188030524 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on MYR Group (MYRG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Shares of MYR Group, Inc. (NASDAQ:MYRG) have been given a consensus recommendation of “Hold” by the ten analysts that are currently covering the company, Marketbeat.com reports. Six analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $35.83.

Top 10 Stocks To Own For 2019: Legacy Reserves LP(LGCY)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market is a market of individual stocks, though, and even with major benchmarks having stalled, some companies are enjoying unparalleled success. In particular, TransEnterix (NYSEMKT:TRXC), BeiGene (NASDAQ:BGNE), and Legacy Resources LP (NASDAQ:LGCY) have all quadrupled in price in just a single year, and investors who are just finding out about them want to know if there are further gains in their futures. There aren’t any sure things in investing, but the prospects that all three of these companies have could fuel additional advances if things go right for them.

  • [By Shane Hupp]

    Legacy Reserves LP (NASDAQ:LGCY) hit a new 52-week high and low on Tuesday . The stock traded as low as $8.74 and last traded at $8.63, with a volume of 42189 shares. The stock had previously closed at $8.36.

  • [By Jason Hall]

    Shares of Texas-based independent oil producerLegacy Reserves LP(NASDAQ:LGCY) finished regular trading down by 15.9% on May 22. To add further frustration for some investors, the drop wasn’t tied to any news for the partnership specifically, or for oil producers in general. As a matter of fact, oil prices climbed on the day, breaching the $80 per-barrel mark briefly before receding a little. Brent crude futures finished the day at $79.49, the highest price for crude oil in more than three years, while West Texas Intermediate — or WTI — futures were relatively flat at around $72 per barrel on the day.

  • [By Money Morning News Team]

    And after taking a look at our 10 top penny stocks to watch, we’ll show you a small-cap stock that just signed a deal with Facebook Inc. (Nasdaq:FB)…

    Penny Stock Current Share Price Law Week’s Gain
    Blink Charging Co. (Nasdaq: BLNK) $6.00 288.51%
    Enterprise GP Holdings LP (NYSE: EPE) $2.94 44.00%
    Opko Health Inc. (Nasdaq: OPK) $4.79 43.49%
    MYnd Analytics Inc. (Nasdaq: MYND) $3.15 38.84%
    Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) $0.52 37.80%
    Mid-Con Energy Partners LP (Nasdaq: MCEP) $2.08 36.81%
    VAALCO Energy (NYSE: EGY) $1.49 36.04%
    Cel-Sci Corp. (NYSE: CVM) $3.16 35.04%
    WideOpenWest Inc. (NYSE: WOW) $8.41 34.52%
    Legacy Reserves LP (Nasdaq: LGCY) $8.43 33.61%

    While these gains are certainly exciting, it’s important to recognize that investing in penny stocks is also a risky investment strategy.

Top 10 Stocks To Own For 2019: Applied Industrial Technologies, Inc.(AIT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Applied Industrial Technologies (NYSE:AIT)’s share price reached a new 52-week high during mid-day trading on Friday . The company traded as high as $76.38 and last traded at $76.35, with a volume of 2108 shares traded. The stock had previously closed at $75.50.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Applied Industrial Technologies (AIT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    AICHAIN (CURRENCY:AIT) traded up 5.1% against the U.S. dollar during the 24 hour period ending at 0:00 AM ET on May 29th. AICHAIN has a total market cap of $13.40 million and approximately $1.60 million worth of AICHAIN was traded on exchanges in the last 24 hours. During the last week, AICHAIN has traded 13.4% lower against the U.S. dollar. One AICHAIN token can now be bought for approximately $0.0250 or 0.00000335 BTC on cryptocurrency exchanges including CoinEgg, BCEX, Allcoin and BigONE.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Applied Industrial Technologies (AIT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Own For 2019: Franklin Resources, Inc.(BEN)

Advisors’ Opinion:

  • [By Max Byerly]

    Millennium Management LLC lessened its holdings in Franklin Resources, Inc. (NYSE:BEN) by 23.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,028,586 shares of the closed-end fund’s stock after selling 308,833 shares during the quarter. Millennium Management LLC owned 0.19% of Franklin Resources worth $35,671,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Franklin Templeton Investments (BEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    State of Alaska Department of Revenue increased its stake in shares of Franklin Resources, Inc. (NYSE:BEN) by 14.9% in the second quarter, HoldingsChannel reports. The firm owned 70,018 shares of the closed-end fund’s stock after buying an additional 9,084 shares during the quarter. State of Alaska Department of Revenue’s holdings in Franklin Resources were worth $2,243,000 at the end of the most recent reporting period.

  • [By Paul Ausick]

    Franklin Resources Inc. (NYSE: BEN) traded down about 2% Wednesday to post a new 52-week low of $32.41 after closing Tuesday at $33.09. The stock’s 52-week high is $47.65. Volume was about equal to the daily average of around 3.6 million shares. The company had no specific news Wednesday.

  • [By Stephan Byrd]

    Press coverage about Franklin Templeton Investments (NYSE:BEN) has trended positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Franklin Templeton Investments earned a coverage optimism score of 0.42 on Accern’s scale. Accern also assigned press coverage about the closed-end fund an impact score of 46.7483317362535 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Top 10 Stocks To Own For 2019: CDK Global, Inc.(CDK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Birch Hill Investment Advisors LLC lessened its position in shares of CDK Global Inc (NASDAQ:CDK) by 0.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 244,208 shares of the software maker’s stock after selling 1,175 shares during the quarter. CDK Global makes up 1.3% of Birch Hill Investment Advisors LLC’s holdings, making the stock its 29th biggest position. Birch Hill Investment Advisors LLC owned about 0.19% of CDK Global worth $15,468,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Rikoon Group LLC lifted its stake in shares of CDK Global Inc (NASDAQ:CDK) by 23.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,873 shares of the software maker’s stock after purchasing an additional 1,102 shares during the quarter. Rikoon Group LLC’s holdings in CDK Global were worth $366,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    These are some of the headlines that may have effected Accern Sentiment’s analysis:

    Get CDK Global alerts:

    CDK announces Connected Workshop concept (am-online.com) CDK Global announces new Connected Workshop concept (cardealermagazine.co.uk) Judge: Car dealer software companies can’t delete antitrust claims over monopolization of car dealer data (cookcountyrecord.com) CDK Global (CDK) vs. Ritchie Bros. Auctioneers (RBA) Head-To-Head Survey (americanbankingnews.com) $578.44 Million in Sales Expected for CDK Global (CDK) This Quarter (americanbankingnews.com)

    CDK has been the subject of a number of research analyst reports. Barrington Research restated a “hold” rating on shares of CDK Global in a research note on Monday, March 26th. BidaskClub lowered shares of CDK Global from a “sell” rating to a “strong sell” rating in a research note on Wednesday, February 21st. Zacks Investment Research lowered shares of CDK Global from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 3rd. Morgan Stanley lifted their price target on shares of CDK Global from $76.00 to $77.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 31st. Finally, Wells Fargo restated an “outperform” rating and issued a $80.00 price target (up previously from $75.00) on shares of CDK Global in a research note on Wednesday, January 31st. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $74.80.

  • [By Ethan Ryder]

    CDK Global Inc (NASDAQ:CDK) announced a quarterly dividend on Thursday, June 7th, NASDAQ reports. Shareholders of record on Tuesday, June 19th will be given a dividend of 0.15 per share by the software maker on Friday, June 29th. This represents a $0.60 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend is Monday, June 18th.

Top 10 Stocks To Own For 2019: Eagle Materials Inc(EXP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Eagle Materials (EXP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Despite some weather issues during the quarter, Eagle Materials (NYSE:EXP) finished its fiscal year on a positive note and delivered record revenue. That solid finish enabled the diversified materials producer to set full-year records for both sales and earnings. Meanwhile, with a strong balance sheet and some tailwinds at its back, the company sees even better days ahead.

  • [By Shane Hupp]

    Barings LLC reduced its holdings in shares of Eagle Materials (NYSE:EXP) by 12.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 110,475 shares of the construction company’s stock after selling 15,166 shares during the period. Barings LLC owned about 0.23% of Eagle Materials worth $11,384,000 at the end of the most recent reporting period.

Top 10 Stocks To Own For 2019: Progress Software Corporation(PRGS)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    The secret to becoming a millionaire, of course, is getting out in front of a major investment trend before it becomes mainstream. In 2017, it was Bitcoin and cryptocurrencies. But this year, it’s a taboo investment that is creating millionaires all across North America. Tap into the “green rush,” and prepare to become a “Marijuana millionaire.” Learn how to get started right here.

    The Top Stock Market Stories for Wednesday
    U.S. President Donald Trump is facing criticism after threatening to ramp up taxes on Harley-Davidson Inc. (NYSE: HOG). The iconic motorcycle producer said it will move parts of its production overseas in order to avoid tariffs from the European Union. Trump threatened to increase taxes on the firm. “Surprised that Harley-Davidson, of all companies, would be the first to wave the White Flag,” Trump tweeted Tuesday. “I fought hard for them and ultimately they will not pay tariffs selling into the E.U., which has hurt us badly on trade, down $151 Billion. Taxes just a Harley excuse – be patient!” Earlier this month,Microsoft Corp.(Nasdaq:MSFT) launched a $7.5 billion takeover of the web-based hosting service GitHub. The acquisition, orchestrated by Microsoft CEO Satya Nadella, brought out critics who claim that GitHub lacks any real profit potential forMicrosoft stock. Here’s why those critics are wrong… and why MSFT is a buy. Facebook Inc. (Nasdaq: FB) has reversed its policy on cryptocurrency ads. The social media giant says that it will permit marketing from “pre-approved advisers.” According to TechCrunch, the company will still ban ads pushing binary options and initial coin offerings. The report goes on to explain that cryptocurrency scams cost customers more than $500 million in just January and February 2018 alone.
    Four Stocks to Watch Today: ORCL, FB, GOOGL, BA
    Oracle Corp. (NYSE: ORCL) were largely flat despite a strong earnings report after the bell yesterday. The cloud computing giant reported EPS of $0.99

  • [By Shane Hupp]

    Smith Asset Management Group LP cut its holdings in shares of Progress Software (NASDAQ:PRGS) by 45.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 61,653 shares of the software maker’s stock after selling 52,380 shares during the period. Smith Asset Management Group LP owned 0.14% of Progress Software worth $2,371,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    Progress Software (NASDAQ:PRGS) posted its quarterly earnings results on Wednesday. The software maker reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.53 by $0.07, RTT News reports. Progress Software had a net margin of 13.86% and a return on equity of 25.03%. The firm had revenue of $96.10 million for the quarter, compared to analyst estimates of $95.03 million. During the same period in the previous year, the business posted $0.42 earnings per share. Progress Software’s quarterly revenue was up 3.1% on a year-over-year basis. Progress Software updated its Q3 guidance to $0.56-$0.58 EPS and its FY18 guidance to $2.45-$2.50 EPS.

Leave a Reply

Your email address will not be published.